ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Revolution Medicines at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Revolution Medicines takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8036. Its program centres on drugs that target RAS-driven cancers. The discussion covers emerging clinical data and next steps for these therapies in non-small cell lung cancer and pancreatic ductal adenocarcinoma.
| Organization | ESMO 2026 Attendance |
|---|---|
US oncology company developing RAS(ON) inhibitors, such as daraxonrasib, for RAS-driven cancers including pancreatic and lung cancer. | Booth Exhibiting at Booth 8036 Satellite Mon Oct 26 18:30–20:00 Revolution Medicines - Advances in RAS-targeted therapies: emerging clinical data and future directions in NSCLC and PDAC Lung & thoracic cancersGastrointestinal cancers |
Find decision makers at Revolution Medicines
Tell us what you sell and we’ll find the people at Revolution Medicines most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction